NASDAQ : BWAY
BrainsWay Ltd. — Key statistics
Healthcare · Medical Devices · Israel
Last price 11.93 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 496.39M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 438.74M |
| Enterprise Value | 386.64M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 40.13M |
| Shares Change (YoY) | +8.77% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 13.48% |
| Owned by Institutions (%) | 26.98% |
| Float | 24.19M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 51.11 |
| Forward PE | 30.82 |
| PS Ratio | 7.38 |
| Forward PS | 5.83 |
| PB Ratio | 5.66 |
| P/TBV Ratio | 5.66 |
| P/FCF Ratio | 77.46 |
| P/OCF Ratio | 59.21 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 41.96 |
| EV / Sales | 6.53 |
| EV / EBITDA | 46.69 |
| EV / EBIT | 52.36 |
| EV / FCF | 68.46 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.59 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 1.23 |
| Interest Coverage | 4.87 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 12.82% |
| Return on Assets (ROA) | 4.05% |
| Return on Invested Capital (ROIC) | 30.70% |
| Return on Capital Employed (ROCE) | 7.62% |
| Weighted Average Cost of Capital (WACC) | 5.05% |
| Revenue Per Employee | $470,504 |
| Profits Per Employee | $73,186 |
| Employee Count | 129 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.60 |
Taxes
| Measure | Value |
|---|
| Income Tax | 236,000 |
| Effective Tax Rate | 2.44% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +33.64% |
| 50-Day Moving Average | 12.89 |
| 200-Day Moving Average | 13.92 |
| Relative Strength Index (RSI) | 39.92 |
| Average Volume (20 Days) | 97,409 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 226,033 |
| Short Previous Month | 250,485 |
| Short % of Shares Out | 0.74% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 60.70M |
| Gross Profit | 45.72M |
| Operating Income | 7.57M |
| Pretax Income | 9.68M |
| Net Income | 9.44M |
| EBITDA | 8.48M |
| EBIT | 7.57M |
| Earnings Per Share (EPS) | $0.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 62.11M |
| Total Debt | 7.13M |
| Net Cash | 54.98M |
| Net Cash Per Share | $1.37 |
| Equity (Book Value) | 79.19M |
| Book Value Per Share | 1.97 |
| Working Capital | 58.75M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 7.57M |
| Capital Expenditures | -1.78M |
| Depreciation & Amortization | 918,000 |
| Net Borrowing | -780,000 |
| Free Cash Flow | 5.79M |
| FCF Per Share | $0.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 75.32% |
| Operating Margin | 12.46% |
| Pretax Margin | 15.94% |
| Profit Margin | 15.55% |
| EBITDA Margin | 13.98% |
| EBIT Margin | 12.46% |
| FCF Margin | 9.53% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.77% |
| Shareholder Yield | -8.77% |
| Earnings Yield | 1.96% |
| FCF Yield | 1.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $19.27 |
| Price Target Difference | 73.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 24.64% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 4, 2026 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 6.15 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |